Stockscreener 앱 받기
87.99
0.99%
0.86
전일 마감가:
$87.13
열려 있는:
$87.23
하루 거래량:
1.01M
Relative Volume:
1.22
시가총액:
$9.26B
수익:
$628.56M
순이익/손실:
$141.82M
주가수익비율:
69.83
EPS:
1.26
순현금흐름:
$142.60M
1주 성능:
+2.19%
1개월 성능:
+12.25%
6개월 성능:
+23.62%
1년 성능:
+56.22%
1일 변동 폭
$86.13
$88.73
1주일 범위
$81.31
$88.73
52주 변동 폭
$49.00
$117.33
코르셉트 테라퓨틱스 Stock (CORT) Company Profile
명칭
Corcept Therapeutics Inc
전화
650.688.8803
주소
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
CORT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
87.99 | 9.17B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
코르셉트 테라퓨틱스 Stock (CORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-06 | 업그레이드 | Truist | Hold → Buy |
| 2023-04-11 | 개시 | SVB Securities | Market Perform |
| 2023-04-04 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-06-27 | 재개 | Canaccord Genuity | Buy |
| 2022-02-02 | 개시 | Canaccord Genuity | Buy |
| 2022-01-28 | 개시 | Truist | Buy |
| 2020-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-09-24 | 개시 | Jefferies | Buy |
| 2019-09-06 | 개시 | H.C. Wainwright | Buy |
| 2019-02-04 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 재확인 | Stifel | Hold |
| 2018-05-31 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-09 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 개시 | Stifel | Buy |
| 2017-02-02 | 개시 | Ladenburg Thalmann | Buy |
| 2015-04-21 | 개시 | FBR Capital | Outperform |
| 2014-01-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2013-08-09 | 다운그레이드 | Janney | Buy → Neutral |
| 2013-08-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-01-06 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | 업그레이드 | Punk, Ziegel & Co | Mkt Perform → Accumulate |
모두보기
코르셉트 테라퓨틱스 주식(CORT)의 최신 뉴스
Assessing Corcept Therapeutics (CORT) Valuation as Relacorilant Nears Key PDUFA Decision and Analyst Optimism Builds - Yahoo Finance
Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects - Yahoo Finance
Invesco Ltd. Sells 214,493 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Analysts see 70% upside potential in Corcept Therapeutics (CORT) stock - MSN
Hsbc Holdings PLC Reduces Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by American Century Companies Inc. - MarketBeat
Epoch Investment Partners Inc. Invests $56.18 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept, Optime file reply for dismissing Teva's US antitrust claims - MLex
Kennedy Capital Management LLC Raises Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Norges Bank Makes New Investment in Corcept Therapeutics Incorporated $CORT - MarketBeat
State Board of Administration of Florida Retirement System Has $4.30 Million Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Is Corcept Therapeutics Incorporated (HTD) stock a buy before new product rolloutEarnings Performance Report & Weekly High Return Stock Forecasts - Newser
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sean Maduck Sells 20,000 Shares - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $397,650.00 in Stock - MarketBeat
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Chief Development Officer At Corcept Therapeutics Sells $364K Of Stock - Benzinga
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Shelton Capital Management Sells 125,365 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Bridge City Capital LLC Sells 22,487 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics Insider Sold Shares Worth $3,190,796, According to a Recent SEC Filing - MarketScreener
Lyon of Corcept Therapeutics sells $397k in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics exec William Guyer sells $1.6m in shares By Investing.com - Investing.com Canada
Officer Guyer Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT] - TradingView
Lyon of Corcept Therapeutics sells $397k in shares - Investing.com
Corcept Therapeutics CEO Belanoff sells $3.19 million in stock By Investing.com - Investing.com Canada
Van Hulzen Asset Management LLC Purchases New Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
3 Growth Companies With High Insider Ownership Seeing 30% Revenue Growth - simplywall.st
Russell Investments Group Ltd. Has $13.67 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by SG Americas Securities LLC - MarketBeat
Officer Guyer Files To Sell 20,000 Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics (CORT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Corcept Therapeutics Incorporated (HTD) stock outperform global peers - Newser
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Korlym Continue to Drive Corcept's Top Line in 2026? - Yahoo Finance
Corcept Therapeutics Incorporated $CORT Shares Sold by Rhumbline Advisers - MarketBeat
F m Investments LLC Invests $1.61 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Capital Fund Management S.A. Trims Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
19,858 Shares in Corcept Therapeutics Incorporated $CORT Acquired by XTX Topco Ltd - MarketBeat
Cushing’s Syndrome Diagnostics and Therapeutics Market, 2034 - Global Market Insights Inc.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Is Largely Controlled by Institutional Shareholders Who Own 69% of the Company - 富途牛牛
Legal & General Group Plc Boosts Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for CORT - MarketBeat
Franklin Resources Inc. Increases Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept (CORT) Q3 2025 Earnings Call Transcript - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $364,050.00 in Stock - MarketBeat
Whale Trades: Will Corcept Therapeutics Incorporated stock deliver strong dividend growthJuly 2025 Chart Watch & Expert Approved Trade Ideas - moha.gov.vn
Chief Development Officer Of Corcept Therapeutics Sold $364K In Stock - Benzinga
What is Zacks Research's Forecast for CORT FY2025 Earnings? - MarketBeat
코르셉트 테라퓨틱스 (CORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):